Category: Neurological

Multiple Sclerosis


More Competition Among Generics is Needed to Lower MS Drug Prices

The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a recent study in Neurology, the medical journal of the American Academy of Neurology.